Home / Resource Library / Sequencing asymmetry: the case for caution before first-line pirtobrutinib in chronic lymphocytic leukemia

Sequencing asymmetry: the case for caution before first-line pirtobrutinib in chronic lymphocytic leukemia

Article discusses pirtobrutinib for first line treatment of CLL.